Diabetes
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Published online May 18, 2007
Diabetes 56:2078-2084, 2007
DOI: 10.2337/db06-1716
© 2007 by the American Diabetes Association
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
db06-1716v1
db06-1716v2
56/8/2078    most recent
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Cuthbertson, D. J.
Right arrow Articles by Rennie, M. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Cuthbertson, D. J.
Right arrow Articles by Rennie, M. J.
Social Bookmarking
 Add to CiteULike   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

5-Aminoimidazole-4-Carboxamide 1-ß-D-Ribofuranoside Acutely Stimulates Skeletal Muscle 2-Deoxyglucose Uptake in Healthy Men

Daniel J. Cuthbertson1, John A. Babraj2, Kirsteen J.W. Mustard3, Mhairi C. Towler4, Kevin A. Green3, Henning Wackerhage4, Graeme P. Leese1, Keith Baar3, Michaela Thomason-Hughes3, Calum Sutherland5, D. Grahame Hardie3, and Michael J. Rennie6

1 Department of Medicine, Ninewells Hospital and Medical School, University of Dundee, Dundee, Scotland
2 School of Life Sciences, Heriot Watt University, Edinburgh, Scotland
3 Division of Molecular Physiology, College of Life Sciences, University of Dundee, Dundee, Scotland
4 College of Life Sciences and Medicine, University of Aberdeen, Aberdeen, Scotland
5 Department of Pharmacology and Neurosciences, University of Dundee, Dundee, Scotland
6 School of Biomedical Sciences, Graduate Entry Medical School, University of Nottingham, Derby City Hospital, Derby, U.K

Address correspondence and reprint requests to Dr. Daniel Cuthbertson, Department of Medicine, Ninewells Hospital and Medical School, Dundee, Scotland DD1 9SY. E-mail: d.j.r.cuthbertson{at}dundee.ac.uk

Abbreviations: 2DG, 2-deoxyglucose; 2DG6P, 2-deoxyglucose 6-phosphate; ACC, acetyl-CoA carboxylase; AICAR, 5-aminoimidazole-4-carboxamide 1-ß-D-ribofuranoside; AMPK, AMP-activated protein kinase; aPKC, atypical protein kinase C; ERK, extracellular signal–regulated kinase; FDG, fluorodeoxyglucose; GS, glycogen synthase; GSK, glycogen synthase kinase; IRS-1, insulin receptor substrate-1; PKB, protein kinase B; ZMP, 5-aminoimidazole-4-carboxamide ribonucleoside

Activation of AMP-activated protein kinase (AMPK) in rodent muscle by exercise, metformin, 5-aminoimidazole-4-carboxamide 1-ß-D-ribofuranoside (AICAR), and adiponectin increases glucose uptake. The aim of this study was to determine whether AICAR stimulates muscle glucose uptake in humans. We studied 29 healthy men (aged 26 ± 8 years, BMI 25 ± 4 kg/m2 [mean ± SD]). Rates of muscle 2-deoxyglucose (2DG) uptake were determined by measuring accumulation of total muscle 2DG (2DG and 2DG-6-phosphate) during a primed, continuous 2DG infusion. The effects of AICAR and exercise on muscle AMPK activity/phosphorylation and 2DG uptake were determined. Whole-body glucose disposal was compared before and during AICAR with the euglycemic-hyperinsulinemic clamp. Muscle 2DG uptake was linear over 9 h (R2 = 0.88 ± 0.09). After 3 h, 2DG uptake increased 2.1 ± 0.8- and 4.7 ± 1.7-fold in response to AICAR or bicycle exercise, respectively. AMPK {alpha}1 and {alpha}2 activity or AMPK phosphorylation was unchanged after 20 min or 3 h of AICAR, but AMPK phosphorylation significantly increased immediately and 3 h after bicycle exercise. AICAR significantly increased phosphorylation of extracellular signal–regulated kinase 1/2, but phosphorylation of ß-acetyl-CoA carboxylase, glycogen synthase, and protein kinase B or insulin receptor substrate-1 level was unchanged. Mean whole-body glucose disposal increased by 7% with AICAR from 9.3 ± 0.6 to 10 ± 0.6 mg · kg–1 · min–1 (P < 0.05). In healthy people, AICAR acutely stimulates muscle 2DG uptake with a minor effect on whole-body glucose disposal.


Add to CiteULike CiteULike   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?





HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Diabetes Diabetes Care Clinical Diabetes Diabetes Spectrum
Copyright © 2007 by the American Diabetes Association.